Evidence-Based Medicine and Stem Cell Therapy: How Do We Know Such Technologies are Safe and Efficacious?

Veterinary Clinics of North America - Equine Practice

Volumn 27, Issue 2, 2011, Pages 373-382

  Clegg, Peter D ^a   Pinchbeck, Gina L ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Evidence based medicine; Horse; Stem cell

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTHROPATHY; EVIDENCE BASED MEDICINE; HORSE; HORSE DISEASE; INJURY; LIGAMENT; REVIEW; STANDARD; STEM CELL TRANSPLANTATION; TENDON INJURY; VETERINARY MEDICINE;

ANIMALS; EVIDENCE-BASED MEDICINE; HORSE DISEASES; HORSES; JOINT DISEASES; LIGAMENTS; STEM CELL TRANSPLANTATION; TENDON INJURIES; VETERINARY MEDICINE;

EQUIDAE;

EID: 80052078087     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2011.04.002     Document Type: Review

References (46)

1. Vaughan L.C., Edwards G.B., Gerring E.L. Tendon injuries in horses treated with carbon fibre implants. Equine Vet J 1985, 17:45-50.
2. Sackett D.L., Rosenberg W.M., Gray J.A., et al. Evidence based medicine: what it is and what it isn't. BMJ 1996, 312:71-72.
3. Holmes M.A., Ramey D.A. An introduction to evidence-based veterinary medicine. Vet Clin North Am Equine Pract 2007, 23(2):191-200.
4. Aragon C.L., Budsberg S.C. Applications of evidence-based medicine: cranial cruciate ligament injury repair in the dog. Vet Surg 2005, 34:93-98.
5. The Oxford 2011 levels of evidence (Oxford Centre for Evidence-Based Medicine) OCEBM Levels of Evidence Working Group, Available at:, Accessed 29 May, 2011. http://www.cebm.net/mod_product/design/files/CEBM-Levels-of-Evidence-2.1.pdf.
6. Sanderson R.O., Beata C., Flipo R.M., et al. Systematic review of the management of canine osteoarthritis. Vet Rec 2009, 164:418-424.
7. Myers E.F., Pritchett E., Johnson E.Q. Evidence-based practice guides vs. protocols: what's the difference?. J Am Diet Assoc 2001, 101:1085-1090.
8. Aragon C.L., Hofmeister E.H., Budsberg S.C. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc 2007, 230:514-521.
9. Innes J.F., Fuller C.J., Grover E.R., et al. Randomised, double-blind, placebo-controlled parallel group study of P54FP for the treatment of dogs with osteoarthritis. Vet Rec 2003, 152:457-460.
10. Davis D.R., Stewart D.J. Autologous cell therapy for cardiac repair. Expert Opin Biol Ther 2011, 11:489-508.
11. Hare J.M., Traverse J.H., Henry T.D., et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
12. Wollert K.C., Meyer G.P., Lotz J., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
13. Lu D., Chen B., Liang Z., et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derivedmononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011, 92:26-36.
14. Duijvestein M., Vos A.C., Roelofs H., et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010, 59:1662-1669.
15. Braude P., Minger S.L., Warwick R.M. Stem cell therapy: hope or hype?. BMJ 2005, 330:1159-1160.
16. Nadig R.R. Stem cell therapy - hype or hope? a review. J Conserv Dent 2009, 12:131-138.
17. Scolding N. Stem-cell therapy: hope and hype. Lancet 2005, 365:2073-2075.
18. Wakitani S., Okabe T., Horibe S., et al. Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months. J Tissue Eng Regen Med 2011, 5:146-150.
19. Nixon A.J., Dahlgren L.A., Haupt J.L., et al. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 2008, 69:928-937.
20. Crovace A., Lacitignola L., De Siena R., et al. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 2007, 31(Suppl 1):281-283.
21. Lacitignola L., Crovace A., Rossi G., et al. Cell therapy for tendinitis, experimental and clinical report. Vet Res Commun 2008, 32(Suppl 1):S33-S38.
22. Schnabel L.V., Lynch M.E., van der Meulen M.C., et al. Mesenchymal stem cells and insulin-like growth factor-I gene-enhanced mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficialis tendons. J Orthop Res 2009, 27:1392-1398.
23. Watts A.E., Yeager A.E., Kopyov O.V., et al. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model. Stem Cell Res Ther 2011, 2(1):4.
24. Guest D.J., Smith M.R., Allen W.R. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine Vet J 2008, 40:178-181.
25. Guest D.J., Smith M.R., Allen W.R. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 2010, 42:636-642.
26. Burk J., Brehm W. Stem cell therapy of tendon injuries-clinical outcome in 98 cases. PFERDEHEILKUNDE 2011, 27(2):153.
27. Pacini S., Spinabella S., Trombi L., et al. Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses. Tissue Eng 2007, 13:2949-2955.
28. Richardson L.E., Dudhia J., Clegg P.D., et al. Stem cells in veterinary medicine-attempts at regenerating equine tendon after injury. Trends Biotechnol 2007, 25:409-416.
29. Smith R.K. Mesenchymal stem cell therapy for equine tendinopathy. Disabil Rehabil 2008, 30:1752-1758.
30. Frisbie D.D., Kisiday J.D., Kawcak C.E., et al. Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis. J Orthop Res 2009, 27:1675-1680.
31. Wilke M.M., Nydam D.V., Nixon A.J. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007, 25:913-925.
32. Dyson S.J. Medical management of superficial digital flexor tendonitis: a comparative study in 219 horses (1992-2000). Equine Vet J 2004, 36:415-419.
33. Milner P, Sidwell S, Talbot A, et al. Short term temporal alterations in MR signal in primary lesions identified in the deep digital flexor tendon of the equine digit. Equine Vet J 2011, in press.
34. Clayton H.M., Schamhardt H.C., Willemen M.A., et al. Kinematics and ground reaction forces in horses with superficial digital flexor tendinitis. Am J Vet Res 2000, 61:191-196.
35. Clayton H.M., Schamhardt H.C., Willemen M.A., et al. Net joint moments and joint powers in horses with superficial digital flexor tendinitis. Am J Vet Res 2000, 61:197-201.
36. Dakin S, Jespers K, Warner S, et al. The relationship between in vivo limb and in vitro tendon mechanics after injury: a potential novel clinical tool for monitoring tendon repair. Equine Vet J 2011, in press. DOI: 10.1111/j.2042-3306.2010.00303.x.
37. Toyras J., Lyyra-Laitinen T., Niinimaki M., et al. Estimation of the Young's modulus of articular cartilage using an arthroscopic indentation instrument and ultrasonic measurement of tissue thickness. J Biomech 2001, 34:251-256.
38. Fortier L.A., Potter H.G., Rickey E.J., et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am 2010, 92:1927-1937.
39. Bashir A., Gray M.L., Boutin R.D., et al. Glycosaminoglycan in articular cartilage: in vivo assessment with delayed Gd(DTPA)(2-)-enhanced MR imaging. Radiology 1997, 205:551-558.
40. Garvican E.R., Vaughan-Thomas A., Innes J.F., et al. Biomarkers of cartilage turnover. Part 1: markers of collagen degradation and synthesis. Vet J 2010, 185:36-42.
41. Garvican E.R., Vaughan-Thomas A., Clegg P.D., et al. Biomarkers of cartilage turnover. Part 2: non-collagenous markers. Vet J 2010, 185:43-49.
42. Aigner T., Cook J.L., Gerwin N., et al. Histopathology atlas of animal model systems-overview of guiding principles. Osteoarthritis Cartilage 2010, 18(Suppl 3):S2-S6.
43. McIlwraith C.W., Frisbie D.D., Kawcak C.E., et al. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage 2010, 18(Suppl 3):S93-S105.
44. Jin H., Lewis J.L. Determination of Poisson's ratio of articular cartilage by indentation using different-sized indenters. J Biomech Eng 2004, 126:138-145.
45. Kiviranta P., Rieppo J., Korhonen R.K., et al. Collagen network primarily controls Poisson's ratio of bovine articular cartilage in compression. J Orthop Res 2006, 24:690-699.
46. Schramme M., Hunter S., Campbell N., et al. A surgical tendonitis model in horses: technique, clinical, ultrasonographic and histological characterisation. Vet Comp Orthop Traumatol 2010, 23:231-239.